2024最新hosts文件

2024最新hosts文件

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

2024最新hosts文件

Learn More
Folded page of a newspaper

2024最新hosts文件

2024最新hosts文件

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

2024最新hosts文件

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

2024最新hosts文件

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

2024最新hosts文件

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

2024最新hosts文件

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

2024最新hosts文件

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

梯子 PC 免费  比特加速官网下载 免费  老王vp官网下载  蜜蜂加速器下载官网  蓝灯外网  电脑用免费梯子